Home / Cancer and immune system / Bleomycin
ATC L01DC01 · Other Cytotoxic Antibiotics
Bleomycin shortage
As of 2 Nov 2026, Bleomycin has a reported shortage in 2 of the 15 countries we track (Canada, Australia), covering 2 products from 1 company.
Countries2/15
Products2packs or presentations
Companies11 listed
Short since–
Earliest return30 Jun 2028company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustralia1 product short
Which companies are short
products short, all countriesListed: Pfizer PFE · NYSE
Compared with similar medicines
ATC group L01DC · Other Cytotoxic AntibioticsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | BLEOMYCIN FOR INJECTION USP (1x1 Vial) anticipated | PFIZER CANADA ULC | 7 Sep 2027 | 31 Dec 2028 | Manufacturing problem Disruption of the manufacture of the drug |
| AU | DBL BLEOMYCIN 15000IU (as sulfate) powder for injection vial anticipated | 22 Dec 2026 | 30 Jun 2028 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.